IVD Medical Holding Limited 華檢醫療控股有限公司

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2020🗂️ Report periods on file: 2020, 2016-12 to 2018-12

In its 2020 reporting, IVD Medical Holding Limited 華檢醫療控股有限公司 disclosed greenhouse gas emissions of 831.26 tCO2e/year. By scope: Scope 1: 434.06 tCO2e/year; Scope 2: 397.20 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
831.26 tCO2e/year
2020
💧
Water Usage
2.2K m3/year
2020
♻️
Waste
5.05 tons/year
2020
⚙️
Energy Use
2.1K MWh/year
2020

📊 Emissions by Scope (2020)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).434.06 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.397.20 tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2020831.26 tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Double the revenue of Sysmex’ 4 Thrombotic Markers in 2021 as compared to 2020
  • Provide solution services to at least two new hospitals in 2021

🌱 ESG Focus Areas

Emissions ControlWaste ManagementUse of ResourcesEmploymentEmployee Health ManagementTraining ManagementPrevention of Child and Forced LabourSupply Chain ManagementFair and Open ProcurementQuality ControlCustomer ServicesPrivacy ProtectionIntellectual Property RightsAnti-corruptionCommunity Investment

⚠️ Challenges & Risks +

  • Heavy reliance on Sysmex
  • Intense competition in the IVD product distribution industry in the PRC due to government policies encouraging the expansion of large distributors through acquisition of smaller ones
  • Temporary decrease in end customers’ demand for IVD products resulting from close-down of hospitals and other quarantine and social distancing measures put in place in mainland China in response to the outbreak of COVID-19

📋 Report Information

Reporting Period: 2020
Frameworks: ESG Reporting Guide (Appendix 27 of the Rules Governing the Listing of Securities on the Main Board of The Stock Exchange of Hong Kong Limited)